179 related articles for article (PubMed ID: 1911189)
1. 31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin: comparison in three sublines with increasing resistance.
Tausch-Treml R; Köpf-Maier P; Baumgart F; Gewiese B; Ziessow D; Scherer H; Wolf KJ
Br J Cancer; 1991 Sep; 64(3):485-93. PubMed ID: 1911189
[TBL] [Abstract][Full Text] [Related]
2. 31P NMR spectroscopy of a xenografted hypopharynx carcinoma: effects of tumor growth and treatment with cisplatin on the tumor phosphorus metabolism, histology and cytokinetics.
Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P
NMR Biomed; 1992; 5(3):127-36. PubMed ID: 1642969
[TBL] [Abstract][Full Text] [Related]
3. 31P NMR study of cisplatin- and doxorubicin-induced changes in tumour metabolism in rats with a cisplatin-sensitive or -resistant immunocytoma.
Sijens PE; van Echteld CJ; van Rijssel RH; Lagendijk JJ; Neijt JP; de Jong WH; van der Minnen AC; de Groot G; Seijkens D
NMR Biomed; 1990 Jun; 3(3):124-31. PubMed ID: 2386659
[TBL] [Abstract][Full Text] [Related]
4. Value of 31P NMR spectroscopy in predicting the response of a xenografted human hypopharynx carcinoma to irradiation.
Jäckel MC; Köpf-Maier P; Baumgart F; Ziessow D; Tausch-Treml R
J Cancer Res Clin Oncol; 2000 Jun; 126(6):325-31. PubMed ID: 10870642
[TBL] [Abstract][Full Text] [Related]
5. In vivo 31P magnetic resonance spectroscopy and 1H magnetic resonance imaging of human bladder carcinoma on nude mice: effects of tumour growth and treatment with cis-dichloro-diamine platinum.
De Certaines JD; Albrectsen J; Larsen VA; Xie X; Rygaard J; Henriksen O
In Vivo; 1992; 6(6):611-6. PubMed ID: 1296810
[TBL] [Abstract][Full Text] [Related]
6. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.
Lyng H; Olsen DR; Southon TE; Rofstad EK
Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356
[TBL] [Abstract][Full Text] [Related]
7. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation.
Lyng H; Olsen DR; Petersen SB; Rofstad EK
NMR Biomed; 1995 Apr; 8(2):65-71. PubMed ID: 7547188
[TBL] [Abstract][Full Text] [Related]
8. P-31 changes as a measure of therapy response in resistant and sensitive osteosarcomas implanted into nude mice.
Ballinger JR; Kang H; Sweeney CA; Scott JD; Croker BP; Scott KN
Magn Reson Imaging; 1995; 13(6):877-83. PubMed ID: 8544659
[TBL] [Abstract][Full Text] [Related]
9. Effect of acquired cisplatin resistance on the response of a xenografted human hypopharynx carcinoma to concurrent radiochemotherapy with cisplatin.
Jäckel M; Tausch-Treml R; Köpf-Maier P
Laryngoscope; 1994 Mar; 104(3 Pt 1):329-34. PubMed ID: 8127191
[TBL] [Abstract][Full Text] [Related]
10. Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas.
Jäckel M; Köpf-Maier P
Cancer Chemother Pharmacol; 1991; 27(6):464-71. PubMed ID: 2013116
[TBL] [Abstract][Full Text] [Related]
11. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
Bremner JC; Counsell CJ; Adams GE; Stratford IJ; Wood PJ; Dunn JF; Radda GK
Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606
[TBL] [Abstract][Full Text] [Related]
12. Increase in the ATP signal after treatment with cisplatin in two different cell lines studied by 31P NMR spectroscopy.
Berghmans K; Ruiz-Cabello J; Simpkins H; Andrews PA; Cohen JS
Biochem Biophys Res Commun; 1992 Feb; 183(1):114-20. PubMed ID: 1543482
[TBL] [Abstract][Full Text] [Related]
13. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
Rose WC; Basler GA
In Vivo; 1990; 4(6):391-6. PubMed ID: 2103379
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell.
Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
Chemotherapy; 1998; 44(6):414-20. PubMed ID: 9755302
[TBL] [Abstract][Full Text] [Related]
15. Development of resistance to cisplatin is associated with decreased expression of the gp185c-erbB-2 protein and alterations in growth properties and responses to therapy in an ovarian tumor cell line.
Langton-Webster BC; Xuan JA; Brink JR; Salomon DS
Cell Growth Differ; 1994 Dec; 5(12):1367-72. PubMed ID: 7696185
[TBL] [Abstract][Full Text] [Related]
16. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
Kjellén E; Wennerberg J; Pero R
Br J Cancer; 1989 Feb; 59(2):247-50. PubMed ID: 2930689
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the anticancer agent cisplatin in the treatment of human cervical squamous carcinoma xenografted in nude mice.
Pillay CV; Green-Thompson R; Brock-Utne JG
Chemotherapy; 1986; 32(4):356-63. PubMed ID: 3731921
[TBL] [Abstract][Full Text] [Related]
18. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
19. Growth studies of subcutaneous rat tumours: comparison of 31P-NMR spectroscopy, acid extracts and histology.
Stubbs M; Rodrigues LM; Griffiths JR
Br J Cancer; 1989 Nov; 60(5):701-7. PubMed ID: 2803946
[TBL] [Abstract][Full Text] [Related]
20. 31P NMR spectroscopy measurements of human ovarian carcinoma xenografts: relationship to tumour volume, growth rate, necrotic fraction and differentiation status.
Rofstad EK; DeMuth P; Sutherland RM
Radiother Oncol; 1988 Aug; 12(4):315-26. PubMed ID: 3187070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
